Trace metals' abnormalities in hemodialysis patients: Relationship with medications

Su Hui Lee, Jenq Wen Huang, Kuan Yu Hung, Li Jer Leu, Yao Tung Kan, Chwei Shiun Yang, Der Chung Wu, Chao Lin Huang, Pei-Yuan Chen, Jui San Chen, Wan Yu Chen

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

A multicenter collaborative study was performed to investigate the prevalence of abnormal blood contents of 6 trace metals, copper (Cu), zinc (Zn), aluminum (Al), lead (Pb), cadmium (Cd), and mercury (Hg), in hemodialysis (HD) patients and to analyze their relationship with the medications, such as CaCO3, Ca acetate, Al containing phosphate-binding agents, 1,25-dihydroxy vitD3, 1-hydroxy vitD3, and erythropoietin (EPO), as well as hematocrit level, by chi-square statistics. From 6 medical centers in Taiwan, we included 456 patients in maintenance HD for more than 4 months for this study, and they had continued the previously mentioned medications for at least 3 months. Blood samples were collected before initiating HD, and atomic absorption spectrophotometry was used to measure plasma levels of Cu, Zn, and Al as well as whole blood levels of Pb, Cd, and Hg. Three hundred seventy-five (78%) of the HD patients had low plasma Zn levels, that is, 50 μg/L, and the mean (±SD) was 44.30 (±28.28) μg/L in all subjects. Three hundred thirty-three (73%) of the dialysis patients had high Cd levels, that is, >2.5 μg/L, and the mean (±SD) was 3.32 (±1.49) μg/L in all subjects. The majority of HD patients had normal blood levels of Cu, PB, and Hg. Only 21 (4.6%), 5 (1.1%), and 3 (0.06%) patients had elevated blood levels of Cu, Pb, and Hg, respectively. Their mean (±SD) blood concentration of Cu, Pb, and Hg were 1,049.78 (±233.25) μg/L, 7.45 (±3.95) μg/dL, and 3.17 (±25.56) μg/L, respectively. Three patients had elevated plasma Hg concentrations, that is, 546, 12.6, and 24.0 μg/L, respectively. In the 152 normal healthy age and sex matched control group, the blood levels of Al, Cd, and Pb were all significantly lower than the HD patients. However, the levels of Cu and Zn were higher in the control group. The Hg level was not significantly different in both groups. There was no statistical difference between patients with normal and abnormal blood levels of trace metals in various medications except Al containing phosphate binder. The Al containing phosphate binder users had significantly higher plasma Al levels (54.71 ± 26.70 versus 41.15 ± 28.03 μg/L, p <0.001) and hematocrit levels (29.61 ± 4.61 versus 27.81 ± 3.91, p <0.0005). There was no statistical correlation between erythropoietin (EPO) dose and hematocrit level in these patients. In conclusion, the blood level of trace metals of these HD patients except Al was not related to their medications. However, caution must be exercised in interpreting this result as dose and duration of medication; efficiency of HD and water treatment may play an important role. Otherwise, environmental factors, diet, and the aging process may contribute to the trace metal burden in uremia. Thus, Zn and Cu are abundant in seafood, and Cd is abundant in contaminated plants such as rice.

Original languageEnglish
Pages (from-to)841-844
Number of pages4
JournalArtificial Organs
Volume24
Issue number11
DOIs
Publication statusPublished - 2000

Fingerprint

Aluminum
Renal Dialysis
Blood
Metals
Cadmium
Zinc
Plasmas
Phosphates
Hematocrit
Erythropoietin
Binders
Dialysis
Trace metals
Spectrophotometry
Nutrition
Blood Group Antigens
Mercury (metal)
Mercury
Water treatment
Atomic Spectrophotometry

Keywords

  • Hemodialysis
  • Medication
  • Trace metal

ASJC Scopus subject areas

  • Biophysics

Cite this

Lee, S. H., Huang, J. W., Hung, K. Y., Leu, L. J., Kan, Y. T., Yang, C. S., ... Chen, W. Y. (2000). Trace metals' abnormalities in hemodialysis patients: Relationship with medications. Artificial Organs, 24(11), 841-844. https://doi.org/10.1046/j.1525-1594.2000.06352.x

Trace metals' abnormalities in hemodialysis patients : Relationship with medications. / Lee, Su Hui; Huang, Jenq Wen; Hung, Kuan Yu; Leu, Li Jer; Kan, Yao Tung; Yang, Chwei Shiun; Wu, Der Chung; Huang, Chao Lin; Chen, Pei-Yuan; Chen, Jui San; Chen, Wan Yu.

In: Artificial Organs, Vol. 24, No. 11, 2000, p. 841-844.

Research output: Contribution to journalArticle

Lee, SH, Huang, JW, Hung, KY, Leu, LJ, Kan, YT, Yang, CS, Wu, DC, Huang, CL, Chen, P-Y, Chen, JS & Chen, WY 2000, 'Trace metals' abnormalities in hemodialysis patients: Relationship with medications', Artificial Organs, vol. 24, no. 11, pp. 841-844. https://doi.org/10.1046/j.1525-1594.2000.06352.x
Lee, Su Hui ; Huang, Jenq Wen ; Hung, Kuan Yu ; Leu, Li Jer ; Kan, Yao Tung ; Yang, Chwei Shiun ; Wu, Der Chung ; Huang, Chao Lin ; Chen, Pei-Yuan ; Chen, Jui San ; Chen, Wan Yu. / Trace metals' abnormalities in hemodialysis patients : Relationship with medications. In: Artificial Organs. 2000 ; Vol. 24, No. 11. pp. 841-844.
@article{29ac4fb886f34357a139348085abe516,
title = "Trace metals' abnormalities in hemodialysis patients: Relationship with medications",
abstract = "A multicenter collaborative study was performed to investigate the prevalence of abnormal blood contents of 6 trace metals, copper (Cu), zinc (Zn), aluminum (Al), lead (Pb), cadmium (Cd), and mercury (Hg), in hemodialysis (HD) patients and to analyze their relationship with the medications, such as CaCO3, Ca acetate, Al containing phosphate-binding agents, 1,25-dihydroxy vitD3, 1-hydroxy vitD3, and erythropoietin (EPO), as well as hematocrit level, by chi-square statistics. From 6 medical centers in Taiwan, we included 456 patients in maintenance HD for more than 4 months for this study, and they had continued the previously mentioned medications for at least 3 months. Blood samples were collected before initiating HD, and atomic absorption spectrophotometry was used to measure plasma levels of Cu, Zn, and Al as well as whole blood levels of Pb, Cd, and Hg. Three hundred seventy-five (78{\%}) of the HD patients had low plasma Zn levels, that is, 50 μg/L, and the mean (±SD) was 44.30 (±28.28) μg/L in all subjects. Three hundred thirty-three (73{\%}) of the dialysis patients had high Cd levels, that is, >2.5 μg/L, and the mean (±SD) was 3.32 (±1.49) μg/L in all subjects. The majority of HD patients had normal blood levels of Cu, PB, and Hg. Only 21 (4.6{\%}), 5 (1.1{\%}), and 3 (0.06{\%}) patients had elevated blood levels of Cu, Pb, and Hg, respectively. Their mean (±SD) blood concentration of Cu, Pb, and Hg were 1,049.78 (±233.25) μg/L, 7.45 (±3.95) μg/dL, and 3.17 (±25.56) μg/L, respectively. Three patients had elevated plasma Hg concentrations, that is, 546, 12.6, and 24.0 μg/L, respectively. In the 152 normal healthy age and sex matched control group, the blood levels of Al, Cd, and Pb were all significantly lower than the HD patients. However, the levels of Cu and Zn were higher in the control group. The Hg level was not significantly different in both groups. There was no statistical difference between patients with normal and abnormal blood levels of trace metals in various medications except Al containing phosphate binder. The Al containing phosphate binder users had significantly higher plasma Al levels (54.71 ± 26.70 versus 41.15 ± 28.03 μg/L, p <0.001) and hematocrit levels (29.61 ± 4.61 versus 27.81 ± 3.91, p <0.0005). There was no statistical correlation between erythropoietin (EPO) dose and hematocrit level in these patients. In conclusion, the blood level of trace metals of these HD patients except Al was not related to their medications. However, caution must be exercised in interpreting this result as dose and duration of medication; efficiency of HD and water treatment may play an important role. Otherwise, environmental factors, diet, and the aging process may contribute to the trace metal burden in uremia. Thus, Zn and Cu are abundant in seafood, and Cd is abundant in contaminated plants such as rice.",
keywords = "Hemodialysis, Medication, Trace metal",
author = "Lee, {Su Hui} and Huang, {Jenq Wen} and Hung, {Kuan Yu} and Leu, {Li Jer} and Kan, {Yao Tung} and Yang, {Chwei Shiun} and Wu, {Der Chung} and Huang, {Chao Lin} and Pei-Yuan Chen and Chen, {Jui San} and Chen, {Wan Yu}",
year = "2000",
doi = "10.1046/j.1525-1594.2000.06352.x",
language = "English",
volume = "24",
pages = "841--844",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Trace metals' abnormalities in hemodialysis patients

T2 - Relationship with medications

AU - Lee, Su Hui

AU - Huang, Jenq Wen

AU - Hung, Kuan Yu

AU - Leu, Li Jer

AU - Kan, Yao Tung

AU - Yang, Chwei Shiun

AU - Wu, Der Chung

AU - Huang, Chao Lin

AU - Chen, Pei-Yuan

AU - Chen, Jui San

AU - Chen, Wan Yu

PY - 2000

Y1 - 2000

N2 - A multicenter collaborative study was performed to investigate the prevalence of abnormal blood contents of 6 trace metals, copper (Cu), zinc (Zn), aluminum (Al), lead (Pb), cadmium (Cd), and mercury (Hg), in hemodialysis (HD) patients and to analyze their relationship with the medications, such as CaCO3, Ca acetate, Al containing phosphate-binding agents, 1,25-dihydroxy vitD3, 1-hydroxy vitD3, and erythropoietin (EPO), as well as hematocrit level, by chi-square statistics. From 6 medical centers in Taiwan, we included 456 patients in maintenance HD for more than 4 months for this study, and they had continued the previously mentioned medications for at least 3 months. Blood samples were collected before initiating HD, and atomic absorption spectrophotometry was used to measure plasma levels of Cu, Zn, and Al as well as whole blood levels of Pb, Cd, and Hg. Three hundred seventy-five (78%) of the HD patients had low plasma Zn levels, that is, 50 μg/L, and the mean (±SD) was 44.30 (±28.28) μg/L in all subjects. Three hundred thirty-three (73%) of the dialysis patients had high Cd levels, that is, >2.5 μg/L, and the mean (±SD) was 3.32 (±1.49) μg/L in all subjects. The majority of HD patients had normal blood levels of Cu, PB, and Hg. Only 21 (4.6%), 5 (1.1%), and 3 (0.06%) patients had elevated blood levels of Cu, Pb, and Hg, respectively. Their mean (±SD) blood concentration of Cu, Pb, and Hg were 1,049.78 (±233.25) μg/L, 7.45 (±3.95) μg/dL, and 3.17 (±25.56) μg/L, respectively. Three patients had elevated plasma Hg concentrations, that is, 546, 12.6, and 24.0 μg/L, respectively. In the 152 normal healthy age and sex matched control group, the blood levels of Al, Cd, and Pb were all significantly lower than the HD patients. However, the levels of Cu and Zn were higher in the control group. The Hg level was not significantly different in both groups. There was no statistical difference between patients with normal and abnormal blood levels of trace metals in various medications except Al containing phosphate binder. The Al containing phosphate binder users had significantly higher plasma Al levels (54.71 ± 26.70 versus 41.15 ± 28.03 μg/L, p <0.001) and hematocrit levels (29.61 ± 4.61 versus 27.81 ± 3.91, p <0.0005). There was no statistical correlation between erythropoietin (EPO) dose and hematocrit level in these patients. In conclusion, the blood level of trace metals of these HD patients except Al was not related to their medications. However, caution must be exercised in interpreting this result as dose and duration of medication; efficiency of HD and water treatment may play an important role. Otherwise, environmental factors, diet, and the aging process may contribute to the trace metal burden in uremia. Thus, Zn and Cu are abundant in seafood, and Cd is abundant in contaminated plants such as rice.

AB - A multicenter collaborative study was performed to investigate the prevalence of abnormal blood contents of 6 trace metals, copper (Cu), zinc (Zn), aluminum (Al), lead (Pb), cadmium (Cd), and mercury (Hg), in hemodialysis (HD) patients and to analyze their relationship with the medications, such as CaCO3, Ca acetate, Al containing phosphate-binding agents, 1,25-dihydroxy vitD3, 1-hydroxy vitD3, and erythropoietin (EPO), as well as hematocrit level, by chi-square statistics. From 6 medical centers in Taiwan, we included 456 patients in maintenance HD for more than 4 months for this study, and they had continued the previously mentioned medications for at least 3 months. Blood samples were collected before initiating HD, and atomic absorption spectrophotometry was used to measure plasma levels of Cu, Zn, and Al as well as whole blood levels of Pb, Cd, and Hg. Three hundred seventy-five (78%) of the HD patients had low plasma Zn levels, that is, 50 μg/L, and the mean (±SD) was 44.30 (±28.28) μg/L in all subjects. Three hundred thirty-three (73%) of the dialysis patients had high Cd levels, that is, >2.5 μg/L, and the mean (±SD) was 3.32 (±1.49) μg/L in all subjects. The majority of HD patients had normal blood levels of Cu, PB, and Hg. Only 21 (4.6%), 5 (1.1%), and 3 (0.06%) patients had elevated blood levels of Cu, Pb, and Hg, respectively. Their mean (±SD) blood concentration of Cu, Pb, and Hg were 1,049.78 (±233.25) μg/L, 7.45 (±3.95) μg/dL, and 3.17 (±25.56) μg/L, respectively. Three patients had elevated plasma Hg concentrations, that is, 546, 12.6, and 24.0 μg/L, respectively. In the 152 normal healthy age and sex matched control group, the blood levels of Al, Cd, and Pb were all significantly lower than the HD patients. However, the levels of Cu and Zn were higher in the control group. The Hg level was not significantly different in both groups. There was no statistical difference between patients with normal and abnormal blood levels of trace metals in various medications except Al containing phosphate binder. The Al containing phosphate binder users had significantly higher plasma Al levels (54.71 ± 26.70 versus 41.15 ± 28.03 μg/L, p <0.001) and hematocrit levels (29.61 ± 4.61 versus 27.81 ± 3.91, p <0.0005). There was no statistical correlation between erythropoietin (EPO) dose and hematocrit level in these patients. In conclusion, the blood level of trace metals of these HD patients except Al was not related to their medications. However, caution must be exercised in interpreting this result as dose and duration of medication; efficiency of HD and water treatment may play an important role. Otherwise, environmental factors, diet, and the aging process may contribute to the trace metal burden in uremia. Thus, Zn and Cu are abundant in seafood, and Cd is abundant in contaminated plants such as rice.

KW - Hemodialysis

KW - Medication

KW - Trace metal

UR - http://www.scopus.com/inward/record.url?scp=0033669028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033669028&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1594.2000.06352.x

DO - 10.1046/j.1525-1594.2000.06352.x

M3 - Article

C2 - 11119069

AN - SCOPUS:0033669028

VL - 24

SP - 841

EP - 844

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 11

ER -